8.15000 EUR
0.416
5.38%
Last update Dec 15, 9:34 AM CET
Main market
Day range
7.34200
8.15000
Previous close
7.73400
Open
7.34200
Access this stock data via API
Subscribe
Intellia Therapeutics Inc.
8.15
0.42
5.38%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 49.3M 36.3M 52.1M 33.1M
Cost of revenue
Gross profit
Operating expense
Research & development 397.2M 435.1M 420.0M 229.8M
Selling general and admin 107.2M 116.5M 90.3M 71.1M
Other operating expenses
Operating income -455.1M -515.3M -458.2M -267.9M
Non operating interest income
Income 40.7M 49.8M 8.5M 1.3M
Expense
Other income expense -27.7M -15.7M -24.6M -1.3M
Pretax income -442.1M -481.2M -474.2M -267.9M
Tax provision
Net income -442.1M -481.2M -474.2M -267.9M
Basic EPS -5.3 -5.4 -6.2 -3.8
Diluted EPS -5.3 -5.4 -6.2 -3.8
Basic average shares 84.2M 92.3M 79.0M 72.8M
Diluted average shares 84.2M 92.3M 79.0M 72.8M
EBITDA -418.6M -506.2M -437.1M -261.0M
Net income from continuing op. -442.1M -481.2M -474.2M -267.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 39 minutes

10:20
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).